Yuma Regional Medical Center is a hospital in Yuma, Arizona. It began in 1958 under the name Parkview Hospital.

There are 406 beds in Yuma Regional Medical Center.

During the past decade, Yuma Regional Medical Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yuma Regional Medical Center" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Academic and Community Cancer Research United" with 2 trials sponsored and "Mirati Therapeutics Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yuma Regional Medical Center" #1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Yuma Regional Medical Center" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Peripheral Arterial Disease" (3 trials), "Peripheral Artery Disease" (3 trials), "Cardiovascular Diseases" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Yuma Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Yuma Regional Medical Center" are "Drug" (16 trials), "Device" (8 trials), "Biological" (6 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Amivantamab" (2 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yuma Regional Medical Center" are 24 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Yuma Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Yuma Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yuma Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".

Yuma Regional Medical Center has several departments that took part in Clinical trials: "Yuma Cancer Center" - 20 trials